Effect of drug on intermittent claudication with lumbar canal stenosis

Effect of drug on intermittent claudication with lumbar canal stenosis - Drug effect on intermittent claudication

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003367

Enrollment

100

Registered

2010-03-24

Start date

2010-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar canal stenosis

Interventions

anti platelet agent non steroid anti inflamatory drug

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: lumbar degeretive disease intermittent claudication within 30 min without ASO

Exclusion criteria

Exclusion criteria: epidural block within 1 month bleeding severe heart, hepatic or renal failure drug allegy contraindicatio for attendance

Design outcomes

Primary

Measure	Time frame
Xray, MRI, JOA score, VAS, Gait parameters	—

Secondary

Measure	Time frame
Walk distance	—

Countries

Japan

Contacts

Public ContactNagura Takeo

Keio University, School fo Medicine Orthopedic Surgery

nagura@z8.keio.jp0353633812

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026